Your shopping cart is currently empty

13,14-dehydro-15-cyclohexyl Carbaprostacyclin is a chemically stable analog of PGI2. It inhibits the ADP-induced aggregation of human platelets with an ED50 of about 40 nM in PRP and 77 nM in washed platelets, which is comparable to the potency of carbaprostacyclin.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 50 μg | $223 | 35 days | 35 days | |
| 100 μg | $417 | 35 days | 35 days | |
| 500 μg | $1,720 | 35 days | 35 days |
| Description | 13,14-dehydro-15-cyclohexyl Carbaprostacyclin is a chemically stable analog of PGI2. It inhibits the ADP-induced aggregation of human platelets with an ED50 of about 40 nM in PRP and 77 nM in washed platelets, which is comparable to the potency of carbaprostacyclin. |
| Molecular Weight | 346.467 |
| Formula | C21H30O4 |
| Cas No. | 145375-81-1 |
| Smiles | [H][C@]12C[C@@H](O)[C@H](C#CC3(O)CCCCC3)[C@@]1([H])C\C(C2)=C\CCCC(O)=O |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMF: >10 mg/mL (from 6B-PGI2), Sonication is recommended. DMSO: >5 mg/mL (from 6B-PGI2), Sonication is recommended. PBS (pH 7.2): >80 mg/mL (from 6B-PGI2), Sonication is recommended. Ethanol: >20 mg/mL (from 6B-PGI2), Sonication is recommended. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.